• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺功能减退与小肠细菌过度生长之间的关联。

Association between hypothyroidism and small intestinal bacterial overgrowth.

作者信息

Lauritano Ernesto Cristiano, Bilotta Anna Lisa, Gabrielli Maurizio, Scarpellini Emidio, Lupascu Andrea, Laginestra Antonio, Novi Marialuisa, Sottili Sandra, Serricchio Michele, Cammarota Giovanni, Gasbarrini Giovanni, Pontecorvi Alfredo, Gasbarrini Antonio

机构信息

Internal Medicine Department, Catholic University of Sacred Heart, Gemelli Hospital, Largo A. Gemelli, 8, 00168 Rome, Italy.

出版信息

J Clin Endocrinol Metab. 2007 Nov;92(11):4180-4. doi: 10.1210/jc.2007-0606. Epub 2007 Aug 14.

DOI:10.1210/jc.2007-0606
PMID:17698907
Abstract

OBJECTIVES

Small intestinal bacterial overgrowth is defined as an abnormally high bacterial population level in the small intestine. Intestinal motor dysfunction associated with hypothyroidism could predispose to bacterial overgrowth. Luminal bacteria could modulate gastrointestinal symptoms and interfere with levothyroxine absorption. The aims of the present study were to assess the prevalence and clinical pattern of bacterial overgrowth in patients with a history of overt hypothyroidism and the effects of bacterial overgrowth decontamination on thyroid hormone levels.

METHODS

A total of 50 consecutive patients with a history of overt hypothyroidism due to autoimmune thyroiditis was enrolled. Diagnosis of bacterial overgrowth was based on positivity to a hydrogen glucose breath test. Bacterial overgrowth positive patients were treated with 1,200 mg rifaximin each day for a week. A glucose breath test, gastrointestinal symptoms, and thyroid hormone plasma levels were reassessed 1 month after treatment.

RESULTS

A total of 27 patients with a history of hypothyroidism demonstrated a positive result to the breath test (27 of 50, 54%), compared with two in the control group (two of 40, 5%). The difference was statistically significant (P < 0.001). Abdominal discomfort, flatulence, and bloating were significantly more prevalent in the bacterial overgrowth positive group. These symptoms significantly improved after antibiotic decontamination. Thyroid hormone plasma levels were not significantly affected by successful bacterial overgrowth decontamination.

CONCLUSIONS

The history of overt hypothyroidism is associated with bacterial overgrowth development. Excess bacteria could influence clinical gastrointestinal manifestations. Bacterial overgrowth decontamination is associated with improved gastrointestinal symptoms. However, fermenting carbohydrate luminal bacteria do not interfere with thyroid hormone levels.

摘要

目的

小肠细菌过度生长被定义为小肠内细菌数量异常增多。与甲状腺功能减退相关的肠道运动功能障碍可能易导致细菌过度生长。肠腔内细菌可调节胃肠道症状并干扰左甲状腺素的吸收。本研究的目的是评估有明显甲状腺功能减退病史患者中细菌过度生长的患病率和临床模式,以及细菌过度生长清除对甲状腺激素水平的影响。

方法

连续纳入50例因自身免疫性甲状腺炎导致明显甲状腺功能减退病史的患者。细菌过度生长的诊断基于氢葡萄糖呼气试验呈阳性。细菌过度生长阳性的患者每天服用1200mg利福昔明,持续一周。治疗1个月后重新评估葡萄糖呼气试验、胃肠道症状和甲状腺激素血浆水平。

结果

共有27例甲状腺功能减退病史患者呼气试验结果呈阳性(50例中的27例,54%),而对照组中有2例呈阳性(40例中的2例,5%)。差异具有统计学意义(P<0.001)。腹部不适、肠胃胀气和腹胀在细菌过度生长阳性组中更为普遍。抗生素清除后这些症状明显改善。成功清除细菌过度生长对甲状腺激素血浆水平没有显著影响。

结论

明显甲状腺功能减退病史与细菌过度生长的发生有关。过多的细菌可能影响临床胃肠道表现。清除细菌过度生长与胃肠道症状改善有关。然而,发酵碳水化合物的肠腔内细菌不会干扰甲状腺激素水平。

相似文献

1
Association between hypothyroidism and small intestinal bacterial overgrowth.甲状腺功能减退与小肠细菌过度生长之间的关联。
J Clin Endocrinol Metab. 2007 Nov;92(11):4180-4. doi: 10.1210/jc.2007-0606. Epub 2007 Aug 14.
2
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.高剂量利福昔明治疗小肠细菌过度生长
Aliment Pharmacol Ther. 2007 Apr 1;25(7):781-6. doi: 10.1111/j.1365-2036.2007.03259.x.
3
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.小肠细菌过度生长的抗生素治疗:利福昔明与甲硝唑对比
Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):111-6.
4
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.临床试验:利福昔明联合部分水解瓜尔胶在根除小肠细菌过度生长方面比利福昔明单独使用更有效。
Aliment Pharmacol Ther. 2010 Oct;32(8):1000-6. doi: 10.1111/j.1365-2036.2010.04436.x. Epub 2010 Aug 18.
5
Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.有下消化道症状且有既往腹部手术史患者的小肠细菌过度生长
Arch Surg. 2011 Apr;146(4):444-7. doi: 10.1001/archsurg.2011.55.
6
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.利福昔明治疗小肠细菌过度生长的剂量探索性研究。
Aliment Pharmacol Ther. 2005 Jul 1;22(1):31-5. doi: 10.1111/j.1365-2036.2005.02516.x.
7
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.利福昔明(一种不被吸收的口服抗生素)治疗小肠细菌过度生长的疗效。
Am J Med Sci. 2007 May;333(5):266-70. doi: 10.1097/MAJ.0b013e3180536784.
8
Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.质子泵抑制剂治疗期间小肠细菌过度生长的发生率增加。
Clin Gastroenterol Hepatol. 2010 Jun;8(6):504-8. doi: 10.1016/j.cgh.2009.12.022. Epub 2010 Jan 6.
9
Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.利福昔明与金霉素在小肠细菌过度生长短期治疗中的比较
Aliment Pharmacol Ther. 2000 May;14(5):551-6. doi: 10.1046/j.1365-2036.2000.00751.x.
10
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.根除小肠细菌过度生长可减轻肠易激综合征的症状。
Am J Gastroenterol. 2000 Dec;95(12):3503-6. doi: 10.1111/j.1572-0241.2000.03368.x.

引用本文的文献

1
The Role of Gluten in the Development of Autoimmune Thyroid Diseases: A Narrative Review.麸质在自身免疫性甲状腺疾病发展中的作用:一项叙述性综述。
Int J Endocrinol Metab. 2024 Jul 30;22(3):e153730. doi: 10.5812/ijem-153730. eCollection 2024 Jul.
2
Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis.血液代谢物反映肠道微生物群对分化型甲状腺癌的影响:孟德尔随机化分析
BMC Cancer. 2025 Feb 28;25(1):368. doi: 10.1186/s12885-025-13598-y.
3
Association between small intestine bacterial overgrowth and psychiatric disorders.
小肠细菌过度生长与精神障碍的关系。
Front Endocrinol (Lausanne). 2024 Oct 21;15:1438066. doi: 10.3389/fendo.2024.1438066. eCollection 2024.
4
The associations between modifiable risk factors and constipation: a comprehensive mendelian randomization study.可改变的风险因素与便秘的相关性:一项综合的孟德尔随机化研究。
BMC Gastroenterol. 2024 Oct 17;24(1):370. doi: 10.1186/s12876-024-03384-8.
5
Gut Microbiota Changes and Its Potential Relations with Thyroid Disorders: From Composition to Therapeutic Targets.肠道微生物群的变化及其与甲状腺疾病的潜在关系:从组成到治疗靶点
Int J Gen Med. 2024 Aug 26;17:3719-3731. doi: 10.2147/IJGM.S481183. eCollection 2024.
6
Vitamin D: An Essential Nutrient in the Dual Relationship between Autoimmune Thyroid Diseases and Celiac Disease-A Comprehensive Review.维生素 D:在自身免疫性甲状腺疾病和乳糜泻的双重关系中不可或缺的营养物质——全面综述
Nutrients. 2024 Jun 4;16(11):1762. doi: 10.3390/nu16111762.
7
Thyroid disorders and gastrointestinal dysmotility: an old association.甲状腺疾病与胃肠动力障碍:一种古老的关联。
Front Physiol. 2024 May 2;15:1389113. doi: 10.3389/fphys.2024.1389113. eCollection 2024.
8
Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge.小肠细菌过度生长(SIBO)与十二组相关疾病——当前知识状况
Biomedicines. 2024 May 7;12(5):1030. doi: 10.3390/biomedicines12051030.
9
Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis.肠道微生物群调节肠道-甲状腺轴:改善桥本甲状腺炎的新曙光。
Clin Exp Med. 2024 Feb 22;24(1):39. doi: 10.1007/s10238-024-01304-4.
10
Complex relationship between gut microbiota and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study.肠道微生物群与甲状腺功能障碍之间的复杂关系:一项双向双样本孟德尔随机化研究。
Front Endocrinol (Lausanne). 2023 Nov 10;14:1267383. doi: 10.3389/fendo.2023.1267383. eCollection 2023.